Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
We have therefore created several types of special body treatment packages for you
In this study, we revealed that WL-1, an antiviral peptide derived from cathelicidins with low toxicity, inhibits the HSV-1 infection in vitro and in vivo , adding antiviral activity to the broad-spectrum function of cathelicidins
Barkmeier AJ, et al
Resources for NDA Submission FDA drug approval documents for NDA submission should include the following data that provide the drugs complete history: Clinical test results Drug ingredients Animal study results The behavior of the drug when it is applied Manufacturing, processing, and packaging processes Furthermore, the following resources can guide you through the new drug application process, while assistance from CDER can help you meet the requirements, internal NDA review principles, policies, and procedures
R.DiniL.BalestraE.DagostiniC.et al (1995)
US$ 22.78
US$ 25.18
US$ 29.00
US$ 22.61
